Close

Amgen (AMGN) Announces Breakthrough Therapy Designation Granted For Sotorasib In China

Go back to Amgen (AMGN) Announces Breakthrough Therapy Designation Granted For Sotorasib In China
Amgen Inc (NASDAQ: AMGN) Delayed: 286.30 +4.53 (1.61%)
Previous Close $281.77    52 Week High $176.85 
Open $284.22    52 Week Low $133.64 
Day High $286.82    P/E 43.12 
Day Low $282.55    EPS $6.64 
Volume 2,256,153